Delivery Order SPE2DB22D3016-SPE2DB26FAAH6
Award Date 10/21/25
Potential Completion Date 10/22/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,239.50 to AmerisourceBergen Drug Corp for the supply of Hemabate 250 micrograms/milliliter ampules. This non-competitive, firm fixed-price delivery order was issued on July 29, 2025, with a completion date of July 30, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Hemabate is a uterotonic medication used in obstetric and gynecological applications, supporting the Defense...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Hemabate 250 micrograms per milliliter in ampule form. This firm fixed-price delivery order, valued at $2,119.75, is non-set-aside and scheduled for completion by September 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,119.75 delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/mL ampules, with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.85 to AmerisourceBergen Drug Corp for the supply of Hemabate 250 micrograms per milliliter in ampule format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,271.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/ml ampules, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement delivered to the place of performance in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills this order under its...
- The Defense Logistics Agency awarded a delivery order valued at $4,059.35 to AmerisourceBergen Drug Corp for Hemabate 250 MCG/ML ampules, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEMABATE 250 MCG/ML ampules, with a ceiling value of $4,239.50 under a firm fixed-price contract structure. This non-set-aside award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. HEMABATE (carboprost tromethamine) is a pharmaceutical product used in obstetric and gynecological applications. The performance location is AmerisourceBergen Drug Corp's corporate...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,666.41, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hemabate 250 mcg/mL ampules. The contract has a ceiling value of $1,811.65 and a completion date of September 13, 2023. It is a firm-fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., the parent company, which holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,781.85 firm-fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a completion date of February 4, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...